MedTrace Logo

Cardiac Resynchronization Therapy in Pulmonary Hypertension

NCT03077139 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2017-09-20

No results posted yet for this study

Summary

This study is being conducted to determine whether patients with advanced pulmonary hypertension when treated with cardiac resynchronization therapy improve hemodynamically and/or receive clinical benefit.

Conditions

  • Pulmonary Hypertension

Interventions

DEVICE

Cardiac Resynchronization Therapy (CRT)

A CRT device sends small electrical impulses to both lower chambers of the heart to help them beat together in a more synchronized pattern.

Sponsors & Collaborators

  • Dr. Daniel P Morin, MD MPH FHRS

    lead OTHER

Principal Investigators

  • Daniel Morin, MD · Cardiac Electrophysiologist

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-29
Primary Completion
2017-03-23
Completion
2017-03-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03077139 on ClinicalTrials.gov